Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Palatnik

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The American Journal of Tropical Medicine and Hygiene|August 1, 1997
Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patientsK G Luz, V O da Silva, E M Gomes, et al.
Vaccine|September 6, 2002
Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo do Amarante, RN)G P Borja-Cabrera, N N Correia Pontes, V O da Silva, et al.
American Journal of Physical Anthropology|June 1, 2001
Genetic relationships between Amerindian populations of ArgentinaA S Goicoechea, F R Carnese, C Dejean, et al.
Vaccine|March 25, 2006
Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasisE Oliveira-Freitas, C P Casas, G P Borja-Cabrera, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 25, 2020
Trabecular and cortical bone involvement in rheumatoid arthritis by DXA and DXA-based 3D modellingM L Brance, B A Pons-Estel, N J Quagliato, et al.
Vaccine|July 17, 2007
Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccineF N Santos, G P Borja-Cabrera, L M Miyashiro, et al.
Vaccine|October 6, 2009
Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasisG P Borja-Cabrera, F N Santos, F B Santos, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The American Journal of Tropical Medicine and Hygiene|August 1, 1997
Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patientsK G Luz, V O da Silva, E M Gomes, et al.
Vaccine|September 6, 2002
Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo do Amarante, RN)G P Borja-Cabrera, N N Correia Pontes, V O da Silva, et al.
American Journal of Physical Anthropology|June 1, 2001
Genetic relationships between Amerindian populations of ArgentinaA S Goicoechea, F R Carnese, C Dejean, et al.
Vaccine|March 25, 2006
Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasisE Oliveira-Freitas, C P Casas, G P Borja-Cabrera, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 25, 2020
Trabecular and cortical bone involvement in rheumatoid arthritis by DXA and DXA-based 3D modellingM L Brance, B A Pons-Estel, N J Quagliato, et al.
Vaccine|July 17, 2007
Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccineF N Santos, G P Borja-Cabrera, L M Miyashiro, et al.
Vaccine|October 6, 2009
Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasisG P Borja-Cabrera, F N Santos, F B Santos, et al.
Pageof 6